Features of left ventricular remodeling in hypothyroidism and ischemic heart disease on the background of chronic systemic inflammation
Journal Title: Міжнародний ендокринологічний журнал - Year 2019, Vol 15, Issue 2
Abstract
Background. Thyroid dysfunction in modern medical science is regarded as one of the risk factors for cardiovascular diseases, unfortunately, unwittingly underestimated. It is known that even insignificant violations of thyroid function can be accompanied by the increased cardiometabolic risk. Hypothyroidism already on the early (subclinical) stage has a significant influence on formation and development of cardiovascular diseases. The results of large researches demonstrate that subclinical hypothyroidism is associated with increased risk for the development of ischemic heart disease, myocardial infarction and death rate from cardiovascular diseases. The purpose of this research is to study the structural and functional status of the left ventricular myocardium in hypothyroidism, ischemic heart disease and in comorbidity. Materials and methods. One hundred and forty clinical records were analyzed and 55 patients with hypothyroidism, ischemic heart disease and combined pathology were examined. They were divided into 3 groups: the first group — 81 patients with hypothyroidism, the second group — 67 individuals with ischemic heart disease, and the third group — 67 people with combination of hypothyroidism and ischemic heart disease. Control group included 20 persons aged 20 to 25 years. Results. It was found that myocardial hypertrophy developed in all groups of patients; the decrease of thyroid function is characterized by myocardial remodeling with the development of eccentric hypertrophy, with the progression of systolic dysfunction in case of comorbidity. A direct correlation was found between reduced ejection fraction and higher levels of interleukin-8. Conclusions. Activation of chronic systemic inflammation is more significant in comorbidity, with negative prognostic influence on the state of the cardiovascular system. The decline of thyroid function results in the development of left myocardial hypertrophy with subsequent changes in cardiac geometry towards eccentric remodeling. Hypothyroidism is characterized by impaired central hemodynamics; manifestations of systolic dysfunction are increased in combination of thyroid pathology and ischemic heart disease. Activation of chronic systemic inflammation is more significant in comorbidity, with negative prognostic influence on the state of the cardiovascular system.
Authors and Affiliations
O. Yu. Horodynska, L. E. Bobyrova, O. V. Izmailova, A. F. Baranova
Keywords
Related Articles
- EP ID EP605131
- DOI 10.22141/2224-0721.15.2.2019.166104
- Views 58
- Downloads 0
Vitamin-mineral premix and treatment of diffusive nontoxic goiter
Background. The content of microelements and vitamins was studied in adolescents with diffuse nontoxic goiter (DNG). The purpose of the study is to substantiate the use of vitamin-mineral premixes in the treatment of ado...
Pseudothyroid dysfunction in clinical practice: how to avoid diagnostic errors
The lecture provides modern information about euthyroid sick syndrome (non-thyroidal illness syndrome). Data are presented on the possible causes and mechanisms of thyroid homeostasis disorders under various physiologica...
Characteristic of Developmental Disabilities in Adolescent Boys in Tashkent According to Screening Data
In this article, the authors analyze the 343 cases of examination of adolescent boys in Tashkent (Republic of Uzbekistan). We detected various violations of sexual and overall development in 170 adolescents (49.6 %), of...
Influence of Hypoglycemic Therapy on the Body Weight Dynamics
The lecture examines the impact of treatment with different groups of hypoglycemic drugs on the body weight of patients with type 2 diabetes mellitus. The schemes for rational pharmacotherapy of patients with type 2 diab...
Assessment of Glycemia Impact on the Parameters of Sleep in Type 1 Diabetes Mellitus: the Results of Cross-Sectional Cohort Trial
This study demonstrates the impact of glycemia according to daily monitoring of blood glucose on parameters of nocturnal sleep in type 1 diabetic patients, regardless of the glycated haemoglobin level.